BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33573266)

  • 1. SSnet: A Deep Learning Approach for Protein-Ligand Interaction Prediction.
    Verma N; Qu X; Trozzi F; Elsaied M; Karki N; Tao Y; Zoltowski B; Larson EC; Kraka E
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Learning-Based Modeling of Drug-Target Interaction Prediction Incorporating Binding Site Information of Proteins.
    D'Souza S; Prema KV; Balaji S; Shah R
    Interdiscip Sci; 2023 Jun; 15(2):306-315. PubMed ID: 36967455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Hybrid Neural Network Deep Learning Method for Protein-Ligand Binding Affinity Prediction and De Novo Drug Design.
    Limbu S; Dakshanamurthy S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boosting compound-protein interaction prediction by deep learning.
    Tian K; Shao M; Wang Y; Guan J; Zhou S
    Methods; 2016 Nov; 110():64-72. PubMed ID: 27378654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCN-CPI: Multiscale Convolutional Network for Compound-Protein Interaction Prediction.
    Wang S; Jiang M; Zhang S; Wang X; Yuan Q; Wei Z; Li Z
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
    Hudson IL
    Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep neural network affinity model for BACE inhibitors in D3R Grand Challenge 4.
    Wang B; Ng HL
    J Comput Aided Mol Des; 2020 Feb; 34(2):201-217. PubMed ID: 31916049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bionoi: A Voronoi Diagram-Based Representation of Ligand-Binding Sites in Proteins for Machine Learning Applications.
    Feinstein J; Shi W; Ramanujam J; Brylinski M
    Methods Mol Biol; 2021; 2266():299-312. PubMed ID: 33759134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DeepDTAF: a deep learning method to predict protein-ligand binding affinity.
    Wang K; Zhou R; Li Y; Li M
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33834190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Ligand-based Big Data Deep Neural Network Models for Virtual Screening of Large Compound Libraries.
    Xiao T; Qi X; Chen Y; Jiang Y
    Mol Inform; 2018 Nov; 37(11):e1800031. PubMed ID: 29882343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting protein-ligand binding residues with deep convolutional neural networks.
    Cui Y; Dong Q; Hong D; Wang X
    BMC Bioinformatics; 2019 Feb; 20(1):93. PubMed ID: 30808287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning methods for protein torsion angle prediction.
    Li H; Hou J; Adhikari B; Lyu Q; Cheng J
    BMC Bioinformatics; 2017 Sep; 18(1):417. PubMed ID: 28923002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WDL-RF: predicting bioactivities of ligand molecules acting with G protein-coupled receptors by combining weighted deep learning and random forest.
    Wu J; Zhang Q; Wu W; Pang T; Hu H; Chan WKB; Ke X; Zhang Y
    Bioinformatics; 2018 Jul; 34(13):2271-2282. PubMed ID: 29432522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based drug design with geometric deep learning.
    Isert C; Atz K; Schneider G
    Curr Opin Struct Biol; 2023 Apr; 79():102548. PubMed ID: 36842415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning models for drug-target interactions: current knowledge and future directions.
    D'Souza S; Prema KV; Balaji S
    Drug Discov Today; 2020 Apr; 25(4):748-756. PubMed ID: 32171918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery.
    Tsou LK; Yeh SH; Ueng SH; Chang CP; Song JS; Wu MH; Chang HF; Chen SR; Shih C; Chen CT; Ke YY
    Sci Rep; 2020 Oct; 10(1):16771. PubMed ID: 33033310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The power of deep learning to ligand-based novel drug discovery.
    Baskin II
    Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequences.
    Lee I; Keum J; Nam H
    PLoS Comput Biol; 2019 Jun; 15(6):e1007129. PubMed ID: 31199797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new paradigm for applying deep learning to protein-ligand interaction prediction.
    Wang Z; Wang S; Li Y; Guo J; Wei Y; Mu Y; Zheng L; Li W
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38581420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.